Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
ESMO 2018
Biotech
ESMO18: Bayer and Loxo post latest positive data for larotrectinib
Bayer and Loxo Oncology have published the latest updated data for larotrectinib at ESMO.
Ben Adams
Oct 22, 2018 9:21am
ESMO18: Merck’s STING agonist lacks bite on its own
Oct 22, 2018 8:55am
ESMO18: Tazemetostat update sets Epizyme up for first FDA filing
Oct 22, 2018 8:00am
ESMO18: Novartis PI3K combo therapy boosts survival
Oct 20, 2018 10:30am
